Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Recurrent Adult Lymphoblastic Lymphoma; Recurrent B Acute Lymphoblastic Leukemia; Recurrent T Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia; Refractory Lymphoblastic Lymphoma; Refractory T Acute Lymphoblastic Leukemia Interventions: Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Dexamethasone; Biological: Filgrastim-sndz; Drug: Leucovorin; Drug: Mercaptopurine; Drug: Mesna; Drug: Methotrexate; Biological: Pegfilgrastim; Drug: Prednisone; Biological: Rituximab; Biological: Tagrax ofusp-erzs; Drug:...
Source: ClinicalTrials.gov - September 2, 2021 Category: Research Source Type: clinical trials